Cargando…
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain
Non-viral gene therapy of the brain is enabled by the development of plasmid DNA brain delivery technology, which requires the engineering and manufacturing of nanomedicines that cross the blood-brain barrier (BBB). The development of such nanomedicines is a multi-faceted problem that requires progr...
Autor principal: | Pardridge, William M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757841/ https://www.ncbi.nlm.nih.gov/pubmed/35047884 http://dx.doi.org/10.3389/fmedt.2020.602236 |
Ejemplares similares
-
Brain gene therapy with Trojan horse lipid nanoparticles
por: Pardridge, William M.
Publicado: (2023) -
Plasmid DNA gene therapy of the Niemann-Pick C1 mouse with transferrin receptor-targeted Trojan horse liposomes
por: Jiang, Dahai, et al.
Publicado: (2020) -
The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier
por: Boado, Ruben J., et al.
Publicado: (2011) -
Multiple Sclerosis: LIFNano-CD4 for Trojan Horse Delivery of the Neuro-Protective Biologic “LIF” Into the Brain: Preclinical Proof of Concept
por: de la Flor, Raul, et al.
Publicado: (2021) -
Immunotherapeutic Activities of a DNA Plasmid Carrying the Mycobacterial hsp65 Gene (DNAhsp65)
por: Silva, Celio Lopes, et al.
Publicado: (2020)